Stifel Reiterates Buy Rating on Everus (ECG)

April 7, 2025 7:15 AM UTC Send to a Friend
Stifel analyst Brian Brophy reiterated a Buy rating and $67.00 price target on Everus (NYSE: ECG).The analyst commented, “We recently ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login